Segment Information

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Segment Information

Note 20 – Segment Information

The Company is an operating, acquisition, and investment business. Subsidiaries in which the Company has a controlling financial interest are consolidated. The Company has two reportable segments; 1) the cannabis and medical marijuana segment which includes the cost basis of membership interests of Electrum, the contractual interest in the Electrum legal recovery, the notes receivable from G Farma, the contractual interest in the G Farma legal recovery, the equity in G Farma Equity Entities, finance leases to G Farma and finance leases to Pueblo West, the operation of subsidiaries in the cannabis and medical marijuana sector, and in 2019, included the fair value of cannabis stock securities investments, and 2) the Company’s long standing investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their facility related operating costs. The Company also had small investments in securities listed on the NYSE and NASDAQ, an investment in note receivable from a non-affiliated party, the fair value of convertible notes receivable and accrued interest from NeuCourt, and the investment in NeuCourt that is included in the Corporate, Other, and Eliminations section below. The NeuCourt investments were previously reported as an investment that would be useful in the cannabis space, however, NeuCourt has determined that its legal services would likely be more useful to users outside of the cannabis space. Prior period segment information presented below contains reclassification of NeuCourt investments from the cannabis and medical marijuana segment to the Corporate, other, and eliminations segment.

	Cannabis and Medical Marijuana Segment			Facilities Operations Related			Corporate, Other, and Eliminations			Consolidated
2021
Net sales	$	40,764		$	5,969,674		$	-		$	6,010,438
Operating income (loss)		26,849			95,336			(526,521	)		(404,336	)
Interest income		-			3			70,226			70,229
Interest expense		-			38,330			24,062			62,392
Total assets		900,484			2,240,047			1,645,910			4,786,441
Property additions		-			160,102			1,264			161,366
Fixed asset depreciation and amortization		-			45,936			5,744			51,710
2020
Net sales	$	47,707		$	4,778,249		$	-		$	4,825,956
Operating income (loss)		(13,258	)		(231,162	)		(829,684	)		(1,074,104	)
Interest income		-			-			92,571			92,571
Interest expense		-			34,711			584			35,295
Total assets		1,042,553			1,874,519			1,524,023			4,441,095
Property additions		-			126,396			7,593			133,989
Fixed asset depreciation and amortization		-			20,553			7,103			27,656

Mentor Capital, Inc.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes for the years ended December 31, 2021 and 2020, as presented in the consolidated income statements:

	2021			2020
Operating loss	$	(404,336	)	$	(1,074,104	)
Realized gain (loss) on investments in securities		1,017			(14,961	)
Gain on sale of GlauCanna rights		-			31,000
Impairment of investments		22,718			(139,148	)
Interest income		70,229			92,571
Interest expense		(62,392	)		(35,295	)
Gain (loss) on equipment disposals		86			67
PPP loan forgiven		87,122			452,348
EIDL Grant		-			10,000
Other income		38,870			10,031
Income before income taxes	$	(246,686	)	$	(667,491	)